Clinical Trial Update: Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family [NA]

View source ↗

Summary

The post-market clinical follow-up study for Biotronik's Amvia/Solvia pacemaker family has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia
• Heart Failure

Snippet

Sponsor: Biotronik SE & Co. KG | Conditions: Bradycardia, Heart Failure | NA | Status: COMPLETED